Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Bioorganic & Medicinal Chemistry|September 19, 2009
Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R)Daniela Stokmaier, Oleg Khorev, Brian Cutting, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2009
A molecular insight into complement evasion by the staphylococcal complement inhibitor protein familyDaniel Ricklin, Apostolia Tzekou, Brandon L Garcia, et al.
Nature Immunology|June 9, 2009
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorSuzan H M Rooijakkers, Jin Wu, Maartje Ruyken, et al.
The EMBO Journal|March 26, 2016
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding modeFederico Forneris, Jin Wu, Xiaoguang Xue, et al.
Cancer Immunology, Immunotherapy : CII|December 10, 2016
Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.
Immunobiology|January 22, 2016
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patientsChristoph Q Schmidt, Markus J Harder, Eva-Maria Nichols, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertaseJordan L Woehl, Daphne A C Stapels, Brandon L Garcia, et al.
Blood|February 6, 2014
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuriaAntonio M Risitano, Daniel Ricklin, Yijun Huang, et al.
Cancer Immunology, Immunotherapy : CII|January 10, 2018
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.
Haematologica|January 12, 2019
Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating moleculeElisabetta Lombardi, Alessandro Matte, Antonio M Risitano, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry|September 19, 2009
Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R)Daniela Stokmaier, Oleg Khorev, Brian Cutting, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2009
A molecular insight into complement evasion by the staphylococcal complement inhibitor protein familyDaniel Ricklin, Apostolia Tzekou, Brandon L Garcia, et al.
Nature Immunology|June 9, 2009
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorSuzan H M Rooijakkers, Jin Wu, Maartje Ruyken, et al.
The EMBO Journal|March 26, 2016
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding modeFederico Forneris, Jin Wu, Xiaoguang Xue, et al.
Cancer Immunology, Immunotherapy : CII|December 10, 2016
Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.
Immunobiology|January 22, 2016
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patientsChristoph Q Schmidt, Markus J Harder, Eva-Maria Nichols, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertaseJordan L Woehl, Daphne A C Stapels, Brandon L Garcia, et al.
Blood|February 6, 2014
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuriaAntonio M Risitano, Daniel Ricklin, Yijun Huang, et al.
Cancer Immunology, Immunotherapy : CII|January 10, 2018
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapyXiaopeng Yuan, Mingjuan Yang, Xiang Chen, et al.
Haematologica|January 12, 2019
Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating moleculeElisabetta Lombardi, Alessandro Matte, Antonio M Risitano, et al.
Pageof 14